Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00070889 · ClinicalTrials.gov registry record
Brain Cell Injury in Patients With A First Episode of Psychosis
A clinical trial, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- 30
- Enrollment target
NCT00070889 is a clinical trial that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 30 participants.
The verdict
NCT00070889 has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Patients experiencing a first episode of psychosis may have brain cell damage due to a chemical process called oxidation. This study will compare patients with psychosis to healthy volunteers to determine if there are differences in their blood that reflect oxidative brain cell damage.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 1999-09 |
| Est. Completion | 2004-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00070889
The ClinicalTrials.gov registry entry for NCT00070889 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Complementary and Integrative Health (NCCIH), which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00070889 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00070889 about?
NCT00070889 is a clinical study titled "Brain Cell Injury in Patients With A First Episode of Psychosis". Patients experiencing a first episode of psychosis may have brain cell damage due to a chemical process called oxidation. This study will compare patients with psychosis to healthy volunteers to determine if there are differences in their blood that reflect oxidative brain cell damage.
What is the current status of trial NCT00070889?
This trial is currently completed. The enrollment target is 30 participants. The study started on 1999-09. Estimated completion is 2004-08.
Who is sponsoring clinical trial NCT00070889?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.